NFE2L2 and cancer: However, NRF2 signaling could be highly context-dependent; for example, GPX4 could be either upregulated or downregulated by NRF2 in different cancer cell lines [260], making NRF2 a multifaceted modulator of the anti-ferroptotic response [298].